Gary S Roubin has bought NSPR on 8 days since Feb 2021
Director at InspireMD, Inc.
SEC CIK 0001162533 · Filings on SEC.gov ↗
Gary S Roubin's record
3 months after each buy, from the first price a copier could get.
5 buys since 2021 with 3 months of prices.
Every filing
8 filings since Feb 2021, newest first
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
Inspiremd, Inc.
Director
About Gary S Roubin
Dr. Gary S. Roubin, M.D., Ph.D. is an internationally renowned interventional cardiologist and Director of InspireMD, Inc. (NYSE: NSPR) since October 2020.( He is celebrated for pioneering carotid stenting, embolic protection devices, and the development of the first FDA-approved coronary stent, which he placed in 1987.( His career includes serving as Chief of Interventional Cardiology at the University of Alabama at Birmingham, where he was Professor of Medicine and Radiology, and later as Department Chairman and Chief of Service at Lenox Hill Hospital's Cardiac and Vascular program in New York.( Dr. Roubin has co-authored over 280 peer-reviewed papers, edited three textbooks on interventional cardiology, and received the Texas Heart Institute's 2024 Ray C. Fish Award for Scientific Achievement.(
On May 7, 2026, Roubin purchased 90,000 shares of InspireMD stock at $1.18 per share, valued at $106,200, increasing his ownership to 834,478 shares (a 12.09% rise).( He holds 10 issued U.S. and EU patents and 41 additional applications, contributing to biotech startups through his clinical expertise.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.